March 27, 2013 — UC Davis stem cell researcher Paul Knoepfler has added a unique honor to his curriculum vitae: He is among the winners of the California Institute for Regenerative Medicine’s (CIRM) first-ever Elevator Pitch Challenge, which were announced today.
March 1, 2013 — Frederic A. Troy, II, professor and chair emeritus of biochemistry and molecular medicine, has received a globally competitive research grant from the Mizutani Foundation for Glycoscience to better understand structural changes associated with metastasis of adult cancer cells and stem cells.
UC Davis scientist receives funding from Shriners Hospitals for Children for juvenile arthritis research
January 18, 2013 — Iannis Adamopoulos, a researcher dedicated to studying diseases of the immune and skeletal systems, has received $1 million in grants from Shriners Hospitals for Children to find new treatment targets for juvenile arthritis — the most common cause of orthopaedic disability among children.
January 10, 2013 — UC Davis stem cell researcher Paul Knoepfler has named Roman Reed as his first "Stem Cell Person of the Year" awardee.
December 12, 2012 — The California Institute for Regenerative Medicine (CIRM), the state’s stem cell agency, today approved a $3 million research grant for Emanual Maverakis, a UC Davis dermatologist who is exploring the development of a synthetic biomaterial that would enable stem cells to be used as effective therapies for chronic skin ulcers.
December 4, 2012 — Chong Pan has been recognized by the National Cancer Institute (NCI) with a Cancer Clinical Investigator Team Leadership Award. Pan, associate professor of medicine and leader of the cancer center’s urothelial carcinoma initiative, was one of 11 award recipients for FY 2011. Formal recognition of the recipients took place recently at the National Institutes of Health in Bethesda, MD.
November 16, 2012 — Borrowing a thematic page from Time magazine and its annual tradition of identifying an individual or idea that has influenced the events during the year, UC Davis stem cell researcher Paul Knoepfler is seeking nominees for what he's dubbed the "Stem Cell Person of the Year" award.
October 29, 2012 — The UC Davis Alzheimer's Disease Center will hold its first annual research symposium and poster session, titled "What's Good for the Body is Good for the Brain," on Thursday, Nov. 1, from 4 p.m. to 6:30 p.m. in lecture hall 2222 in the Education Building, 4610 X St., Sacramento, Calif.
UC Davis researchers find multiple similarities between cancer cells and induced pluripotent stem cells
September 28, 2012 — UC Davis investigators have found new evidence that a promising type of stem cell now being considered for a variety of disease therapies is very similar to the type of cells that give rise to cancer.
September 12, 2012 — Deborah K. Lieu, a stem cell scientist in cardiovascular medicine at UC Davis Health System, has received a $1.3 million research grant from the California Institute for Regenerative Medicine (CIRM) to develop stem cells that could serve as a biological alternative to the electronic pacemakers that people now use to regulate heart rhythm.
August 21, 2012 — For the second consecutive year, Paul Knoepfler, associate professor of cell biology and human anatomy at UC Davis School of Medicine, has been awarded a $100,000 grant from the St. Baldrick's Foundation to pursue his novel research into the molecular causes of brain tumors in children.
July 26, 2012 — UC Davis Health System researchers who are working to speed therapies to patients suffering from critical limb ischemia, osteoporosis and Huntington's disease received approval today for three separate research grants from the state's stem cell agency totaling more than $53 million. [en español]
July 26, 2012 — UC Davis Health System researchers working to speed therapies to patients suffering from critical limb ischemia (CLI) received approval today for a $14.1 million grant from the state's stem cell agency, the California Institute for Regenerative Medicine (CIRM).
July 26, 2012 — Researchers at UC Davis Health System in Sacramento have received approval for a $20 million grant proposal to refine a stem cell therapy for osteoporosis patients and test its effectiveness in clinical trials over the next four years.
July 26, 2012 — In what scientists and patients advocates say is an exciting development in the area of Huntington's disease (HD) research, California's stem cell agency today approved a grant proposal worth nearly $20 million that is designed to propel researchers at UC Davis Health System toward preparing for the first FDA-approved cellular therapy for HD patients.
June 27, 2012 — Three multidisciplinary teams of UC Davis researchers have been awarded IDEA grants from the California Breast Cancer Research Program.